Clinical trial Recruiting at 8 sites Interventional Ages 18 to 65

Tight management for shoulder pain from rotator cuff tendinopathy

Official title: Efficacy of Tight Treatment in Rotator Cuff Tendinopathy Rotator Cuff Tendinopathy: a Randomized Controlled Trial Versus Standard Standard Management

Run by Nantes University Hospital · NCT06517680 · Data updated 2026-11-12

This study is testing if more regular check-ins and support for people with early shoulder pain from rotator cuff tendinopathy can help them feel better faster compared to just one visit after three months.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment156 (estimated)
SponsorNantes University Hospital
Academic / other
Locations8 sites (Angers and 7 other locations)
StatusRecruiting
StartedNovember 25, 2024
Main results expectedNovember 25, 2027
Study endsNovember 25, 2027
Registry record updatedJanuary 15, 2026
Trial IDNCT06517680 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 to 65 with new-onset shoulder pain related to rotator cuff tendinopathy lasting less than six months.

Probably not a fit

Patients with shoulder pain due to trauma, previous surgeries, or other specific shoulder disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate whether close management of patients with early rotator cuff tendinopathy leads to better clinical outcomes compared to standard management. Participants will be randomly assigned to either a tight control group, receiving monthly consultations for three months, or a control group, which will have a single consultation after three months. The hypothesis is that more frequent follow-ups will result in quicker improvements and reduce the risk of chronic pain, along with a cost analysis of healthcare consumption and work absenteeism. The study addresses a common and costly issue affecting many adults, particularly those aged 45 to 64.

Why it matters

Potential benefit: If successful, this approach could lead to faster recovery and reduced chronicity for patients suffering from rotator cuff tendinopathy.

How similar studies have gone: Previous studies have indicated that structured management approaches can be more effective than standard care, suggesting potential success for this study's methodology.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria :

Patient with new-onset shoulder pain related to rotator cuff tendinopathy

* Age between 18 and 65
* Shoulder pain on activity for less than 6 months with VAS≥4/10 and/or OSS≥20
* Pain compatible with rotator cuff tendinopathy according to the rotator cuff tendinopathy according to the BESS (British Elbow and Shoulder Society) guidelines

Exclusion Criteria:

* Contraindication to steroid injections
* Shoulder pain related to trauma (dislocation, fracture) or acute tendon rupture requiring short-term surgery
* Steroid injection already performed on the shoulder studied for the current episode
* Neurological pathology affecting the shoulder
* Other shoulder disorders (inflammatory arthritis, frozen shoulder, glenohumeral joint instability, pain associated with acromioclavicular arthropathy)
* Tendon calcification \> 0.5 cm.
* Previous shoulder surgery
* Full-thickness tear of one tendon
* Pregnant women

Where it's running

  • CHU Angers
    Angers, France
    Recruiting
  • CHU de Brest
    Brest, France
    Recruiting
  • CHRU de Tours
    Chambray-lès-Tours, France
    Recruiting
  • CH Cholet
    Cholet, France
    Recruiting
  • CH Vendée
    La Roche-sur-Yon, France
    Recruiting
  • CH du Mans
    Le Mans, France
    Recruiting
Show 2 more locations
  • CHU de Nantes
    Nantes, France
    Recruiting
  • Chotard Emilie
    Rennes, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.